How Kidney Cancer Research Benefits From The American Recovery and Reinvestment Act of 2009

 In this email to our CEO, Bill Bro, Shannon Bell, Director, Office of Advocacy Relations, at the National Cancer Institute, describes new initiatives in kidney cancer research.  Mr. Bro will attend the National Cancer Advisory Board meetings, in Bethesda, in his capacity as a liaison representing cancer survivors.Dear Bill: I would like to take this opportunity to call your attention to several of NCI’s exciting initiatives funded through the American Recovery and Reinvestment Act of 2009 (ARRA) in both cancer research generally and in kidney cancer specifically. I am pleased to report that the National Cancer Institute (NCI) has made significant strides in distributing the $1.26 billion it received under ARRA.  As of mid-November 2009, the NCI has awarded $847 million in ARRA funds.  These awards have enabled us to significantly expand our support of cancer research by increasing the percentage of grants funded, launching new interdisciplinary and collaborative programs, and accelerating clinical trials to get treatments to cancer patients more rapidly. These NCI ARRA investments are not only stimulating the economy through the support of biomedical and behavioral research, they are enabling opportunities for important scientific advances in cancer research.  More detail about NCI’s use of ARRA funds can be found at:http://www.cancer.gov/recovery. To advance our efforts in the area of kidney cancer, the NCI has used A...
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news